glabridin has been researched along with Cancer of Liver in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, MK; Chiou, HL; Hsieh, MJ; Lin, CW; Yang, SF | 1 |
Jiang, F; Li, Y; Li, Z; Mu, J; Ning, S; Si, L; Wang, X; Ye, X | 1 |
Chen, C; Chen, L; He, Z; Huang, G; Huang, Z; Li, B; Luo, S; Wan, Z; Wang, Z; Zhang, X | 1 |
Chen, CJ; Chen, MK; Chiou, HL; Chuang, YC; Hsieh, MC; Hsieh, MJ; Lo, YS; Yang, SF | 1 |
4 other study(ies) available for glabridin and Cancer of Liver
Article | Year |
---|---|
Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9 through modulation of NF-κB and AP-1 activity in human liver cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Humans; Isoflavones; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; Male; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Phenols; Phosphorylation; Signal Transduction; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Transcription Factor AP-1; Transcription, Genetic; Transfection; Xenograft Model Antitumor Assays | 2014 |
The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Isoflavones; Liver Neoplasms; MicroRNAs; Neoplastic Stem Cells; Phenols; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2014 |
Glabridin arrests cell cycle and inhibits proliferation of hepatocellular carcinoma by suppressing braf/MEK signaling pathway.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Division; Computational Biology; Drug Design; Hep G2 Cells; Humans; Isoflavones; Liver Neoplasms; MAP Kinase Kinase 1; MAP Kinase Signaling System; Models, Molecular; Phenols; Phosphorylation; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins B-raf; Tumor Stem Cell Assay | 2016 |
Glabridin induces apoptosis and autophagy through JNK1/2 pathway in human hepatoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glycyrrhiza; Humans; Isoflavones; Liver Neoplasms; MAP Kinase Signaling System; Membrane Proteins; p38 Mitogen-Activated Protein Kinases; Phenols; Phytotherapy; Plant Extracts; Signal Transduction | 2016 |